Sanofi-Aventis Sues Sandoz Over Taxotere Drug Patent
Sanofi-Aventis is seeking to protect its flagship cancer treatment drug Taxotere in a lawsuit against generics maker Sandoz Inc., alleging Sandoz's abbreviated new drug application with the U.S. Food and Drug...To view the full article, register now.
Already a subscriber? Click here to view full article